Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice

Abstract Cladribine tablets (CladT), like alemtuzumab, acts as an immune reconstitution therapy. However, CladT is administered orally (alemtuzumab is given by infusion) and without the potential for serious side effects that limit the therapeutic use of alemtuzumab in multiple sclerosis (MS). Treat...

Description complète

Détails bibliographiques

Auteurs principaux:	Bassem Yamout, Raed Alroughani, Jihad Inshasi, Samar Farouk, Fatema Abdulla, Namareq Y. Al-Jarki, Abdulla Alasmi, Sarmad Al Fahad, Jaber Alkhabouri, Khalid Al-Saffar, Beatrice Benedetti, Beatriz Canibano, Dirk Deleu, Ali Hassan, Pournamy Sarathchandran, Ahmed Shatila, Mohammad Abouelnaga, Mona Thakre, Miklos Szolics, Amir Boshra
Format:	Artigo
Langue:	Inglês
Publié:	Adis, Springer Healthcare 2024-08-01
Collection:	Neurology and Therapy
Sujets:	Relapsing multiple sclerosis Cladribine tablets Immune reconstitution therapy Disease-modifying therapy
Accès en ligne:	https://doi.org/10.1007/s40120-024-00650-5
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!